NPI: 1376574707 · PHOENIX, AZ 85016 · Ophthalmology Physician · NPI assigned 07/05/2006
Authorized official BROOKFIELD, ARTHUR controls 20+ related entities in our dataset. Read more
| Authorized Official | BROOKFIELD, ARTHUR (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 07/05/2006 |
Other providers sharing the same authorized official: BROOKFIELD, ARTHUR
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 18,700 | $846K |
| 2019 | 21,161 | $963K |
| 2020 | 18,817 | $1.10M |
| 2021 | 21,867 | $1.33M |
| 2022 | 27,931 | $1.75M |
| 2023 | 28,403 | $2.31M |
| 2024 | 27,352 | $2.54M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 20,503 | 19,799 | $2.25M |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 25,819 | 24,344 | $1.92M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 5,605 | 4,293 | $1.53M |
| 92134 | 33,016 | 30,734 | $787K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 9,760 | 8,906 | $725K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 323 | 311 | $678K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 8,243 | 7,123 | $419K |
| J0178 | Injection, aflibercept, 1 mg | 242 | 230 | $382K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8,463 | 7,845 | $247K |
| 92235 | 3,179 | 2,997 | $207K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6,165 | 5,870 | $196K |
| J9035 | Injection, bevacizumab, 10 mg | 1,848 | 1,730 | $175K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2,838 | 2,733 | $162K |
| 92136 | 9,766 | 6,675 | $162K | |
| 67210 | 416 | 317 | $148K | |
| 92250 | 5,328 | 5,161 | $144K | |
| J7999 | Compounded drug, not otherwise classified | 2,176 | 1,744 | $123K |
| 92083 | 2,844 | 2,683 | $98K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2,467 | 2,401 | $96K |
| 92133 | 2,665 | 2,586 | $61K | |
| 66821 | 408 | 334 | $59K | |
| V2020 | Frames, purchases | 642 | 642 | $48K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1,392 | 1,364 | $39K |
| 92285 | 2,515 | 2,375 | $31K | |
| 92025 | 982 | 938 | $27K | |
| 92015 | Determination of refractive state | 1,539 | 1,533 | $26K |
| 92242 | 189 | 182 | $23K | |
| 68841 | 1,834 | 1,477 | $17K | |
| 92020 | 896 | 841 | $15K | |
| 66982 | 50 | 42 | $15K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 222 | 147 | $8K |
| 76514 | 1,025 | 983 | $7K | |
| 92002 | 94 | 87 | $6K | |
| 83861 | 245 | 227 | $6K | |
| 76519 | 213 | 188 | $4K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 206 | 192 | $2K |
| 92081 | 63 | 61 | $1K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 25 | 17 | $896.25 |
| 76512 | 13 | 12 | $339.22 | |
| 92082 | 12 | 12 | $304.06 |